Main trends of immune effects triggered by nanomedicines in preclinical studies
Blanka Halamoda-Kenzaoui, Susanne Bremer-Hoffmann Directorate F-Health, Consumers and Reference Materials, European Commission Joint Research Centre (JRC), Ispra (VA), Italy Abstract: The application of nanotechnology to emerging medicinal products is a crucial parameter for the implementation of...
Enregistré dans:
Auteurs principaux: | Halamoda-Kenzaoui B, Bremer-Hoffmann S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0b56e46c056e4b8399a74ddb452bae6a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
- Nanomedicine journal
- Journal of Interdisciplinary nanomedicine
- European journal of nanomedicine
-
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
par: Giannakou C, et autres
Publié: (2016) -
New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies
par: Giulia Mitola, et autres
Publié: (2021)